(Q36096066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Indicators of functional status for primary malignant brain tumour patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Miguel Bussière

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Wilma Hopman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Andrew Day

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Alicia Paris Pombo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Teresa Neves

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Francisco Espinosa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

50-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

The basis for current treatment recommendations for malignant gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Malignant glioma: who benefits from adjuvant chemotherapy?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Neuro-oncology: an overview

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Management of patients aged over 60 years with supratentorial glioma: lessons from an audit.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Management of primary malignant brain tumours

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Cognitive functioning and quality of life in malignant glioma patients: a review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Successful chemotherapy for recurrent malignant oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Increasing incidence of primary malignant brain tumors: influence of diagnostic methods

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Rising primary malignant brain tumor mortality in the elderly. A manifestation of differential survival

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Treatment of malignant glioma. A controlled study of chemotherapy and irradiation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Treatment of neuroectodermal brain tumors

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Karnofsky performance status revisited: reliability, validity, and guidelines

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Radiation response and survival time in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100016875

7 January 2021

10.1017/S0317167100016875

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825546%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference